跳至主要内容
临床试验/NCT04424368
NCT04424368Unknown不适用

Creation and Evaluation of the Effectiveness of the Remote Monitoring System for Patients, Who Had Myocardial Infarction

Ryazan State Medical University2 个研究点 分布在 2 个国家目标入组 250 人开始时间: 2018年10月3日最近更新:
适应症

试验速览

阶段
不适用
入组人数
250
试验地点
2
主要终点
hospitalization

研究概览

简要总结

one-centered, open, prospective, non-randomized, controlled clinical study will be aimed at creating remote monitoring system for patients' condition and the development of methodological approaches and its usage for conducting patients, who had myocardial infraction and who has a very high risk of developing an unfavorable outcome.

详细描述

The research will involve patients, who had myocardial infraction and who has the high level of potential adherence to treatment, which will be determined by the usage of Russian generic questionnaire for evaluation of compliance to drug therapy. At the end of a 12 month observation with the registration of unfavorable cardiovascular occasions (death from cardiovascular reasons, nonfatal myocardial infraction, cerebral stroke, necessity for repeated revascularization of the coronary arteries) based on the analysis of non-genetic and genetic factors (polymorphism of genes Thr174Met and Met235Thr in gene angiotensinogen, Arg389Gly and Ser49Gly in gene adrenoceptor beta 1, Ser447Ter in gene lipoprotein lipase and Leu28Pro in gene apolipoprotein E, Trp212Ter and G681A in gene cytochrome P450 family 2 subfamily C member 19) factors of unfavorable prognosis will be identified and considering which group of patients requires the use of remote monitoring system will be formed. From one group of patients we will form two comparable groups, one group will use this remote monitoring system and another will not. The effectiveness of the remote monitoring system will be evaluated after 6-month's observation based on the registration of the unfavorable cardiovascular occasions (death from cardiovascular reasons, nonfatal myocardial infraction, cerebral stroke, necessity for repeated revascularization of the coronary arteries, frequency of hospitalizations).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A significant diagnosis of myocardial infraction, confirmed by the level of biomarkers of myocardial necrosis in blood examination (troponin, creatine kinase-MV), electrocardiographic criteria, typical clinical presentation.
  • The high level of adherence to treatment
  • Signed informed agreement

排除标准

  • Active cancer or remission period less than 5 years;
  • Absolute contradictions to the prescription of beta-adrenergic blocking agents, angiotensin converting enzyme inhibitors, statins, antiaggregants.
  • Mental illnesses.
  • Alcohol and drug abuse
  • Patient's noncompliance, according to the researchers

结局指标

主要结局

hospitalization

时间窗: 12 months

frequency of hospitalization about the progression of coronary heart disease

revascularization

时间窗: 12 months

frequency of repeated revascularization of coronary arteries

cardiovascular mortality

时间窗: 12 months

the number of deaths from cardiovascular causes

acute myocardial infarction

时间窗: 12 months

incidence of acute myocardial infarction

cerebral stroke

时间窗: 12 months

incidence of cerebral stroke

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Remote Monitoring System for Patients, Who Had... | 临床试验